Conshohocken-based AdaptHealth Corp., a health care-at-home solutions company, recently announced that it is selling its Diabetes Health business to Cardinal Health for $235 million in cash. The segment provides medical devices and related services to patients for the treatment of diabetes.
“The divestiture of our Diabetes Health business is the latest – and most significant – step in a deliberate, multi-year effort to focus AdaptHealth on our core businesses where we have the strongest competitive position and the clearest path to growth,” Suzanne Foster, AdaptHealth CEO, said. “Over the past two years, we have systematically reshaped our portfolio around our core sleep, respiratory and supporting HME business lines, where we cross the threshold of the home to deliver clinical value to patients.”
The deal is subject to customary purchase price adjustments, regulatory review and other customary closing conditions. The company will discuss the sale on its second quarter 2026 earnings call on Aug. 4.
AdaptHealth now operates under three segments. The Sleep Health segment provides sleep therapy equipment, supplies and related services. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services. The Wellness at Home segment provides home medical equipment and services to patients in their homes.